2005
DOI: 10.1253/circj.69.711
|View full text |Cite
|
Sign up to set email alerts
|

Myocardial Creatine Concentration in Various Nonischemic Heart Diseases Assessed by 1H Magnetic Resonance Spectroscopy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
32
0

Year Published

2007
2007
2021
2021

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 31 publications
(34 citation statements)
references
References 28 publications
2
32
0
Order By: Relevance
“…Metabolite quantification (Table 2) is consistent with previously published data on control tissue [15] and, as found using pattern recognition, showed a reduction of metabolites in ischemic and at-risk areas as compared to controls. This illustrates the possibility of using an hypothesis free approach (pattern recognition) to identify the metabolites most related to the condition under study for a more detailed analysis.…”
Section: Hr-mas Spectrasupporting
confidence: 89%
“…Metabolite quantification (Table 2) is consistent with previously published data on control tissue [15] and, as found using pattern recognition, showed a reduction of metabolites in ischemic and at-risk areas as compared to controls. This illustrates the possibility of using an hypothesis free approach (pattern recognition) to identify the metabolites most related to the condition under study for a more detailed analysis.…”
Section: Hr-mas Spectrasupporting
confidence: 89%
“…The phosphocreatine (PCr)-to-ATP ratio is decreased in many cardiac disorders, including dilated cardiomyopathy, left ventricular hypertrophy, coronary artery disease, and heart failure, as well as infarcted heart (2628). Bioenergetic deficits may predict clinical severity (27,29,30) and are accompanied by decreased creatine content, determined by 1 H-MRS (31), which also characterizes nonviable postischemic myocardium (32). Despite normal left ventricular morphology, mass, and systolic function, diabetic heart exhibits a decreased PCr-to-ATP ratio, which is associated with underlying diastolic dysfunction (33).…”
Section: In Vivo Mrs Studies Of Human Metabolismmentioning
confidence: 99%
“…In a series of 1 H-MRS studies, Nakae et al [38, 7173] have shown a significant reduction in myocardial creatine content in patients with heart failure secondary to non-ischaemic diseases (dilated cardiomyopathy, hypertrophic cardiomyopathy, cardiac amyloidosis or valvular heart disease). All these studies were limited by the small number of patients enrolled, which prevented a statistically powerful individual analysis of each disease.…”
Section: Creatine Metabolismmentioning
confidence: 99%
“…Myocardial creatine concentration correlated positively with cardiac function (LVEF) [38, 71, 73] and free fatty acid uptake [38] and negatively with plasma brain natriuretic peptides (BNP) levels [71, 72]. Finally, total creatine levels could potentially be predictive of subsequent heart failure; Nakae et al [73] showed that creatine levels had been lower in patients who were later admitted to hospital for heart failure in the year following the metabolic assessment (11.3 ± 1.0 vs. 18.6 ± 5.9 µmol/l). However, these findings need to be confirmed prospectively in larger studies and compared with standard predictive markers.…”
Section: Creatine Metabolismmentioning
confidence: 99%